Stocks and Investing Stocks and Investing
Wed, June 10, 2020
Tue, June 9, 2020

Aaron Gal Downgraded (BIIB) to Hold and Decreased Target to $297 on, Jun 9th, 2020


Published on 2024-10-27 07:51:00 - WOPRAI, Aaron Gal
  Print publication without navigation


Aaron Gal of Bernstein, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $360 to $297 on, Jun 9th, 2020.

Aaron has made no other calls on BIIB in the last 4 months.



There are 9 other peers that have a rating on BIIB. Out of the 9 peers that are also analyzing BIIB, 3 agree with Aaron's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alethia Young of "Cantor Fitzgerald" Reiterated at Hold with Decreased Target to $308 on, Friday, May 1st, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Hold with Decreased Target to $310 on, Thursday, April 23rd, 2020
  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $316 on, Tuesday, February 25th, 2020


These are the ratings of the 6 analyists that currently disagree with Aaron


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $350 on, Friday, April 24th, 2020
  • Steven Seedhouse of "Citigroup" Downgraded from Hold to Strong Sell on, Thursday, April 23rd, 2020
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $370 on, Thursday, April 23rd, 2020
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $365 on, Thursday, April 23rd, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $301 on, Thursday, April 23rd, 2020
  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Decreased Target to $330 on, Thursday, April 23rd, 2020
Contributing Sources